A. Aguilar

发表

Definition of Castrate Resistant Prostate Cancer: New Insights

J. Morote, J. Planas, E. Trilla, 2022, Biomedicines.

Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baits

Ryan D. Morin, Daniel Fornika, Jordan Davidson, 2017, Scientific Reports.

Circulating tumor DNA (ctDNA) during and after neoadjuvant chemotherapy and prior to surgery is a powerful prognostic factor in triple-negative breast cancer (TNBC).

A. Robidoux, E. Bareke, N. Alirezaie, 2019, Journal of Clinical Oncology.